CC

ANALYST NOTE: THE CHEMOURS COMPANY (CC) DATE: 2026-06-13 SUBJECT: Structural Setup Analysis & Business Fundamentals

1. Structural Readiness

The instrument is classified within the Coil family. As of the close on 2026-06-13, the setup is CONFIRMED-ACTIVE.

• Conservative Entry: $18.32.
• Current Price: $21.77.
• Extension: The stock is trading +18.8% above the conservative entry level.
• Breakout Level: The breakout occurred at the consolidation of the previous structure, effectively establishing the $18.32 entry zone.
• Volatility Context: The ATR at the time of the breakout was 5.1% (High bucket), indicating strong structural quality and momentum. The current ATR is 5.5% (High bucket), suggesting sustained volatility consistent with the initial breakout energy.

2. Thesis Layer

As of 2026-06-13, there is no named secular thesis attached to this specific setup. This is a TACTICAL, setup-led name.

The conviction for this position is derived strictly from the quality of the technical structure (the confirmed coil breakout) and the immediate business fundamentals reported by management. There is no macro or thematic overlay (e.g., "green energy transition" or "AI infrastructure boom") driving this specific trade signal at this moment. The analysis must rely on the setup's ability to capture momentum and the company's ability to execute on its stated operational guidance.

3. Business Fundamentals

The Chemours Company operates as a global provider of specialized chemical products, organized into four primary divisions: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions.

Operational Performance & Guidance (Source: Q2 2026 Earnings Transcript, 2026-05-06): Management has provided specific sequential guidance for the second quarter of 2026, indicating a period of operational recovery and seasonal strength:

• Net Sales: Management projects consolidated net sales to increase by 15% to 20% sequentially. This is driven by the resumption of normal operations at the Washington works (which contributed to a 30% to 40% sequential increase in the Performance Solutions portfolio) and favorable seasonal trends for the cooling season in the Northern Hemisphere.
• EBITDA: Consolidated adjusted EBITDA is expected to range between $220 million and $250 million. The Performance Solutions (PFS) segment specifically is projected to generate adjusted EBITDA of $210 million to $225 million.
• Segment Drivers:
• Thermal & Specialized Solutions: The TSS business reported a record first quarter, with double-digit year-over-year growth in Freon and Opteon refrigerants. Management notes continued strength in the Freon aftermarket and the transition to Opteon referrers.
• Performance Solutions: Demand remains robust in semiconductor and data center end markets, driving orders for specialized products.
• Titanium Technologies: While not explicitly quantified in the Q2 guidance snippet, the segment remains a core pillar, manufacturing TiO2 pigments (Ti-Pure, BaiMax) used in coatings, plastics, and packaging.

Capital Allocation & Liquidity (Source: 10-Q/8-K Filings, 2026-05-05):

• Asset Monetization: The company is executing a land sale program. In January 2026, agreements were signed to sell ten parcels in Kuan Yin, Taiwan, for ~$360 million. Subsequent to the filing date (April 2026), the company completed the sale of nine parcels, receiving $287 million in net cash proceeds.
• Remaining Asset: Management expects to complete the sale of the remaining parcel in 2026, which should provide an incremental $60 million in gross proceeds.
• Balance Sheet Strength: As of March 31, 2026, the company held $563 million in unrestricted cash and cash equivalents (with $357 million held at foreign subsidiaries). Additionally, there is $953 million of availability under its revolving credit facility.

Market Exposure: The company's products serve critical applications in consumer electronics, semiconductors, oil and gas, water treatment, and automotive sectors. However, management explicitly noted ongoing monitoring of the conflict in the Middle East and resulting energy market volatility as a potential headwind to global demand.

4. Archetype and Conviction

Archetype: Growth Leader (specifically a cyclical recovery with operational inflection).

Rationale: The setup aligns with a "Growth Leader" archetype not because of a speculative narrative, but because the company is demonstrating clear sequential operational acceleration (15-20% sales growth) and margin expansion (EBITDA growth) following a period of disruption (Washington works resumption). The archetype fits the "cyclical recovery" sub-nature, where the company is capitalizing on seasonal demand and operational normalization.

Conviction Stack:

• Thesis Strength: Low (Tactical only, no secular tailwind).
• Evidence Quality: High. Management guidance is specific, quantified, and backed by recent asset sales.
• Structural Quality: High. The ATR at breakout (5.1%) and current ATR (5.5%) place this in the "High" bucket, historically associated with strong trend continuation rather than weak, choppy moves.
• Setup Readiness: Confirmed. The breakout has fired, and the price is extending +18.8% without invalidating the structure.
• Rerating Potential: Moderate. The combination of strong sequential growth, significant cash generation from asset sales, and a clean balance sheet ($953M revolver availability) provides a fundamental floor that supports the technical breakout.

Valuation Context: The financial spine indicates a forward consensus EPS of $1.40 for FY1 and $2.28 for FY2. The current price of $21.77 implies a forward P/E of approximately 15.5x for FY1 and 9.5x for FY2. This valuation compression relative to the growth trajectory (30%+ sequential growth in specific segments) suggests the market is pricing in a recovery that is currently being validated by the technical breakout.

5. Invalidation, Strengthening, and Gaps

What Would Invalidate:

• Fundamental: A significant miss on the Q2 guidance (e.g., sales growth falling below the 15% sequential target) or a delay in the Washington works resumption.
• Macro: Escalation of the Middle East conflict causing a material disruption to the chemical supply chains or energy costs that management cannot pass through.

What Would Strengthen:

• Technical: A sustained move higher with volume, confirming the +18.8% extension is not a "blow-off" top but the start of a new leg.
• Fundamental: Confirmation that the remaining Taiwan land parcel sale closes as expected in 2026, adding the projected $60 million.
• Operational: Continued double-digit growth in the TSS segment beyond the Q1 record, validating the "Freon aftermarket" thesis.

Gaps in Evidence:

• Long-Term Margin Trajectory: While Q2 EBITDA is guided, there is no explicit evidence in the provided block regarding the *sustainability* of these margins beyond the immediate seasonal cycle.
• Capex Plans: There is no specific data on capital expenditure plans for 2026-2027 to support the growth in the semiconductor/data center segments.
• Debt Maturity Schedule: While liquidity is strong, the specific maturity profile of existing debt is not detailed in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: high Key evidence: Confirmed coil breakout with price holding +18.8% above entry; Management guidance for 15-20% sequential sales growth and $220-250M EBITDA; Strong liquidity position with $287M recent cash proceeds from asset sales. Key risks: Potential volatility from Middle East conflict impacting global supply chains; Seasonal demand fading after Q2 cooling season; Execution risk on remaining Taiwan land sale. Sizing hint: Standard position sizing for a confirmed high-ATR breakout; reduce size if extension exceeds 25% without consolidation. Expected path: Management expectations for sequential growth and asset monetization should support continued price appreciation as the market digests the operational recovery. Expected horizon: 3 to 6 months, aligned with the realization of Q2/Q3 seasonal trends and the completion of the Taiwan asset sale. Failure mode to watch: A daily close below $14.43, which would invalidate the structural setup and suggest a failure of the breakout momentum.